Difference between revisions of "Part:BBa K3561018"

Revision as of 15:35, 10 October 2020

G5Q7

This peptide is expected to be a palladium reducing peptide. This peptide is modified by our team from the palladium reducing peptide Q7(Chiu et al., 2010). We have incorporated a glutamine residue at position 5, glutamine was reported as a strong binder, glutamine residues were also found in the active sites of various palladium binding proteins, suggesting an active role in binding. We wish to explore its effects in this peptide.

This peptide has an isoelectric point of 6.0, a molecular weight of 0.80 kDa and hydrophobicity of 16.68. The serine residue at positions 3 and 7 are reported to be important in binding with palladium(Chiu et al., 2010). The tryptophan residue at position 4 is reported to reduce palladium(Chiu et al., 2010). The amino acid sequence of the peptide is QQSWGIS.

References

Chiu, et al. Size-Controlled Synthesis of Pd Nanocrystals Using a Specific Multifunctional Peptide. 2010, pubmed.ncbi.nlm.nih.gov/20648291/.

Sequence and Features

Assembly Compatibility:

10
COMPATIBLE WITH RFC[10]
12
COMPATIBLE WITH RFC[12]
21
COMPATIBLE WITH RFC[21]
23
COMPATIBLE WITH RFC[23]
25
COMPATIBLE WITH RFC[25]
1000
COMPATIBLE WITH RFC[1000]

@@ Line 7: / Line 7: @@
 This peptide has an isoelectric point of 6.0, a molecular weight of 0.80 kDa and hydrophobicity of 16.68. The serine residue at positions 3 and 7 are reported to be important in binding with palladium(Chiu et al., 2010). The tryptophan residue at position 4 is reported to reduce palladium(Chiu et al., 2010). The amino acid sequence of the peptide is QQSWGIS.
+<h2>References</h2>
+Chiu, et al. Size-Controlled Synthesis of Pd Nanocrystals Using a Specific Multifunctional Peptide. 2010, pubmed.ncbi.nlm.nih.gov/20648291/.